- Home
- H vs PODD Comparison
H vs PODD Comparison
Compare H & PODD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- H
- PODD
- Stock Information
- Founded
- H 1957
- PODD 2000
- Country
- H United States
- PODD United States
- Employees
- H N/A
- PODD N/A
- Industry
- H Hotels/Resorts
- PODD Medical/Dental Instruments
- Sector
- H Consumer Discretionary
- PODD Health Care
- Exchange
- H Nasdaq
- PODD Nasdaq
- Market Cap
- H 15.1B
- PODD 16.5B
- IPO Year
- H 2009
- PODD 2007
- Fundamental
- Price
- H $156.08
- PODD $276.08
- Analyst Decision
- H Buy
- PODD Buy
- Analyst Count
- H 19
- PODD 16
- Target Price
- H $154.97
- PODD $271.19
- AVG Volume (30 Days)
- H 443.3K
- PODD 533.0K
- Earning Date
- H 02-13-2025
- PODD 02-20-2025
- Dividend Yield
- H 0.39%
- PODD N/A
- EPS Growth
- H 192.44
- PODD 235.68
- EPS
- H 13.18
- PODD 5.74
- Revenue
- H $6,462,000,000.00
- PODD $1,983,900,000.00
- Revenue This Year
- H $2.43
- PODD $23.56
- Revenue Next Year
- H $3.87
- PODD $18.07
- P/E Ratio
- H $11.84
- PODD $48.28
- Revenue Growth
- H 4.01
- PODD 27.42
- 52 Week Low
- H $125.45
- PODD $160.19
- 52 Week High
- H $168.20
- PODD $282.86
- Technical
- Relative Strength Index (RSI)
- H 51.06
- PODD 61.28
- Support Level
- H $153.91
- PODD $260.84
- Resistance Level
- H $157.81
- PODD $274.45
- Average True Range (ATR)
- H 3.25
- PODD 7.63
- MACD
- H 0.09
- PODD 0.86
- Stochastic Oscillator
- H 67.26
- PODD 75.49
About H Hyatt Hotels Corporation
Hyatt is an operator of owned (4% of total rooms) and managed and franchised (96%) properties across around 20 upscale luxury brands, which includes vacation brands (Apple Leisure Group, Hyatt Ziva, and Hyatt Zilara), the recently launched full-service lifestyle brand Hyatt Centric, the soft lifestyle brand Unbound, the wellness brand Miraval, and the midscale extended-stay brand Studios. Hyatt acquired Two Roads Hospitality in 2018 and Apple Leisure Group in 2021. The regional exposure as a percentage of total rooms is 54% Americas, 22% rest of world, and 23% Asia-Pacific.
About PODD Insulet Corporation
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device and that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the U.S. Food and Drug Administration in 2005, approximately 425,000 insulin-dependent diabetics are using it worldwide.